Kenvue Bounce Back; Boeing Plane Orders; Firefly Miss

On this episode of Stock Movers:
- Kenvue (KVUE) is recouping most on Monday’s drop, as President Trump’s call for pregnant women to avoid Tylenol draws sharp criticism from researchers who say the advice ignores decades of evidence and could endanger mothers and babies. "We believe independent, sound science clearly shows that taking acetaminophen does not cause autism,” Kenvue, a consumer health company whose brands include Tylenol, Listerine and Johnson’s, said in an emailed statement. Kenvue dropped 7.5% on Monday, extending YTD decline to 21%.
- Boeing (BA) is rising on news the US and China are in the final stages of negotiations for a "huge" Boeing aircraft order, according to US Ambassador to China David Perdue. Perdue said the deal is "very important to the president" and "very important to China", and that they are "hopeful that that will turn out to be the case" in the last days or weeks of negotiation.
- Firefly Aerospace (FLY) is falling after it reported second-quarter revenue of $15.5 million, compared to the $16.1 million expected on average by analysts. Firefly's shares fell 8.8% in US postmarket trading to $45.15 after the company announced its first quarterly earning results. Firefly expects 2025 full-year revenue to be between $133 million and $145 million.

See omnystudio.com/listener for privacy information.